- Home
- PRTA vs KE Comparison
PRTA vs KE Comparison
Compare PRTA & KE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- KE
- Stock Information
- Founded
- PRTA 2012
- KE 1961
- Country
- PRTA Ireland
- KE United States
- Employees
- PRTA N/A
- KE N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- KE Electrical Products
- Sector
- PRTA Health Care
- KE Technology
- Exchange
- PRTA Nasdaq
- KE Nasdaq
- Market Cap
- PRTA 472.1M
- KE 459.3M
- IPO Year
- PRTA N/A
- KE N/A
- Fundamental
- Price
- PRTA $9.92
- KE $28.31
- Analyst Decision
- PRTA Buy
- KE Strong Buy
- Analyst Count
- PRTA 9
- KE 1
- Target Price
- PRTA $13.14
- KE $28.00
- AVG Volume (30 Days)
- PRTA 785.0K
- KE 221.8K
- Earning Date
- PRTA 11-11-2025
- KE 11-03-2025
- Dividend Yield
- PRTA N/A
- KE N/A
- EPS Growth
- PRTA N/A
- KE N/A
- EPS
- PRTA N/A
- KE 0.68
- Revenue
- PRTA $10,341,000.00
- KE $1,486,727,000.00
- Revenue This Year
- PRTA N/A
- KE N/A
- Revenue Next Year
- PRTA $602.32
- KE $4.02
- P/E Ratio
- PRTA N/A
- KE $41.63
- Revenue Growth
- PRTA N/A
- KE N/A
- 52 Week Low
- PRTA $4.32
- KE $12.41
- 52 Week High
- PRTA $18.88
- KE $33.19
- Technical
- Relative Strength Index (RSI)
- PRTA 55.31
- KE 46.64
- Support Level
- PRTA $9.98
- KE $27.50
- Resistance Level
- PRTA $10.90
- KE $29.51
- Average True Range (ATR)
- PRTA 0.47
- KE 0.97
- MACD
- PRTA -0.06
- KE -0.20
- Stochastic Oscillator
- PRTA 23.93
- KE 31.96
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About KE Kimball Electronics Inc.
Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.